A new PhD position is available in the research group led by Prof. Dr. med. Tianzuo Zhan at Ruprecht-Karls-Universität Heidelberg, Universitätsmedizin Mannheim. The project focuses on investigating the interaction between Wnt and Ras signaling pathways in colorectal cancer, a critical area in cancer biology and molecular medicine. The group welcomes applicants with backgrounds in biology, biochemistry, pharmacology, molecular medicine, or biotechnology. This opportunity is ideal for candidates interested in cancer research, signal transduction, and molecular mechanisms underlying disease progression.

The research environment offers access to advanced facilities and collaboration within a leading German medical university. While no specific funding details are provided, the position is suitable for those seeking to contribute to impactful cancer research. Eligibility highlights include relevant academic background and interest in the research topic; no explicit requirements for GPA, language tests, or prior experience are mentioned. The application window is open, but no deadline is specified. Interested candidates are encouraged to reach out directly to Prof. Zhan via LinkedIn or university channels for further information and application steps.